| 3.81 0.07 (1.87%) | 09-14 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.84 | 1-year : | 5.66 |
| Resists | First : | 4.15 | Second : | 4.84 |
| Pivot price | 3.93  |
|||
| Supports | First : | 3.34 | Second : | 2.84 |
| MAs | MA(5) : | 3.8 |
MA(20) : | 3.89  |
| MA(100) : | 3.27 |
MA(250) : | 3.91 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 14.2 |
D(3) : | 21.3 |
| RSI | RSI(14): 56 |
|||
| 52-week | High : | 6.66 | Low : | 2.55 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ACB ] has closed above bottom band by 20.8%. Bollinger Bands are 31.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.89 - 3.9 | 3.9 - 3.92 |
| Low: | 3.67 - 3.68 | 3.68 - 3.7 |
| Close: | 3.78 - 3.81 | 3.81 - 3.84 |
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.
Mon, 14 Sep 2026
Curaleaf (CURA.T) vs Aurora Cannabis (ACB.T) is a battle of two badly run companies - Equity.Guru
Mon, 14 Sep 2026
Aurora Cannabis says Curaleaf offer undervalues company (ACB:NASDAQ) - Seeking Alpha
Mon, 14 Sep 2026
Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From The Facts - PR Newswire
Wed, 09 Sep 2026
Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business - PR Newswire
Tue, 11 Aug 2026
AURORA CANNABIS INC. RESPONDS TO PRESS RELEASE OF CURALEAF HOLDINGS, INC. REGARDING INTENTION TO LAUNCH UNSOLICITED TAKE-OVER BID - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 63 (M) |
| Shares Float | 64 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 9.3 (%) |
| Shares Short | 7,910 (K) |
| Shares Short P.Month | 8,000 (K) |
| EPS | -0.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.01 |
| Profit Margin | -38.3 % |
| Operating Margin | -13 % |
| Return on Assets (ttm) | -3.8 % |
| Return on Equity (ttm) | -9.4 % |
| Qtrly Rev. Growth | -8.9 % |
| Gross Profit (p.s.) | 2.19 |
| Sales Per Share | 4.96 |
| EBITDA (p.s.) | -0.48 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -28 (M) |
| Levered Free Cash Flow | -20 (M) |
| PE Ratio | -5.78 |
| PEG Ratio | 0 |
| Price to Book value | 0.63 |
| Price to Sales | 0.76 |
| Price to Cash Flow | -8.6 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|